AGENCY: Food Safety and Inspection Service, USDA.
SUMMARY: This notice announces that the U.S. Department of Agriculture (USDA) is soliciting nominations for membership on the National Advisory Committee on Microbiological Criteria for Foods (NACMCF). FSIS inadvertently published this information with errors on June 30, 2010, at 75 FR 37754. The Agency, therefore, is withdrawing the June 30, 2010, notice and publishing the correct version of the notice below. This notice is being issued to fill twelve vacancies on the NACMCF that resulted from a USDA change in the member term limit. Appointments to the NACMCF for two-year terms will now be renewable for up to two consecutive terms instead of three consecutive terms.
Please note that nominations that were provided in response to the previously issued Federal Register notice dated August 18, 2008 (73 FR 48191) will be considered for these vacancies, so they do not need to be resubmitted.
NACMCF is seeking members with scientific expertise in the fields of epidemiology, food technology, microbiology (food, clinical, and predictive), toxicology, chemistry, risk assessment, infectious disease, biostatistics, and other related sciences. NACMCF is seeking applications from persons from the Federal government, State governments, industry, consumer groups, and academia, as well as all other interested persons with such expertise.
Members who are not Federal government employees will be appointed to serve as non-compensated special government employees (SGEs). SGEs will be subject to appropriate conflict of interest statutes and standards of ethical conduct.
USDA is also seeking nominations for one individual affiliated with a consumer group to serve on the NACMCF. This member will serve as a representative member to provide a consumer viewpoint. This member will not be required to have a scientific background and will not be subject to conflict of interest review.
To receive consideration for serving on the NACMCF, a resume and USDA Advisory Committee Membership Background Information form AD-755 are required. The nominee's typed resume or curriculum vitae must be limited to five one-sided pages and should include educational background, expertise, and a select list of publications. For submissions received that are more than five one-sided pages in length, only the first five pages will be considered.
DATES: Nominations, including the nominee's typed resume or curriculum vitae and a USDA Advisory Committee Membership Background Information form AD-755 must be received by August 9, 2010. USDA Advisory Committee Membership Background Information form AD-755 is available on-line at: http://www.ocio.usda.gov/forms/doc/AD-755.pdf.
ADDRESSES: Resumes and AD-755 forms can be sent by mail, fax, or e-mail to Ms. Karen Thomas-Sharp, Advisory Committee Specialist, USDA, Food Safety and Inspection Service, Room 333 Aerospace Center, 1400 Independence Avenue, SW., Washington, DC 20250-3700, fax number: 202- 690-6634, e-mail address: Karen.Thomas-Sharp@fsis.usda.gov. Please
, if using an overnight courier, use this address: USDA, FSIS, OPHS, Aerospace Center, 901 D Street, SW., Room 378, Washington, DC 20024. The Food Safety and Inspection Service (FSIS) invites interested persons to submit comments on this notice. Comments may be submitted by either of the following methods:
Federal eRulemaking Portal: This Web site provides the ability to type short comments directly into the comment field on this Web page or attach a file for lengthier comments. Go to http://www.regulations.gov. Follow the online instructions at that site for submitting comments.
Mail, including floppy disks or CD-ROMs, and hand- or courier- delivered items: Send to Docket Clerk, USDA, FSIS, Room 2-2127, George Washington Carver Center, 5601 Sunnyside Avenue, Mailstop 5474, Beltsville, MD 20705-5474.
Instructions: All items submitted by mail or electronic mail must include the Agency name and docket number FSIS-2010-0001. Comments received in response to this docket will be made available for public inspection and posted without change, including any personal information, to http://www.regulations.gov.
Docket: For access to background documents or to comments received, go to the FSIS Docket Room at the address listed above between 8:30 a.m. and 4:30 p.m., Monday through Friday. All comments submitted in response to this notice, as well as background information used by FSIS in developing this document, will be available for public inspection in the FSIS Docket Room at the address listed above between 8:30 a.m. and 4:30 p.m., Monday through Friday.
FOR FURTHER INFORMATION CONTACT: Ms. Karen Thomas-Sharp, Advisory Committee Specialist, at the above address or by telephone at 202-690- 6620 or by fax at 202-690-6634.
AGENCY: Environmental Protection Agency (EPA).
SUMMARY: An Exposure Modeling Public Meeting (EMPM) will be held for 1 day on July 27, 2010. This notice announces the location and time for the meeting and sets forth the tentative agenda topics.
DATES: The meeting will be held on July 27, 2010, from 9 a.m. to 4 p.m. To request accommodation of a disability, please contact the person listed under FOR FURTHER INFORMATON CONTACT, preferably at least 10 days prior to the meeting, to give EPA as much time as possible to process your request.
ADDRESSES: The meeting will be held at the Environmental Protection Agency, Office of Pesticide Programs (OPP), One Potomac Yard (South Building), Fourth Floor, South Conference Room (S-4370/80), 2777 S. Crystal Drive, Arlington, VA 22202.
FOR FURTHER INFORMATION CONTACT: Chuck Peck, Environmental Fate and Effects Division (7507P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460- 0001; telephone number: (703) 347-8064; fax number: (703) 305-6309; e- mail address: email@example.com.
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice of meeting.
SUMMARY: Under the Federal Advisory Committee Act, Public Law 92463, EPA gives notice of a public teleconference of the National Advisory Council for Environmental Policy and Technology (NACEPT). NACEPT provides advice to the EPA Administrator on a broad range of environmental policy, technology, and management issues. NACEPT represents diverse interests from academia, industry, non-governmental organizations, and local, State, and tribal governments. The Council will be discussing comments it is developing on the draft EPA FY 2011- 2015 Strategic Plan. The Council will also be discussing the workplans it is developing to respond to EPA's request for advice on workforce issues the Agency is facing and how EPA can best address the needs of vulnerable populations. A copy of the agenda for the meeting will be posted at http://www.epa.gov/ocem/nacept/cal-nacept.htm.
DATES: NACEPT will hold a public teleconference on Thursday, July 22, 2010 from 1 p.m.-4 p.m. Eastern Daylight Time.
ADDRESSES: The meeting will be held in the U.S. EPA East Building, 1201 Constitution Ave., NW., Room 1132, Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT: Nancy New, Acting Designated Federal Officer, firstname.lastname@example.org, (202) 564-0464, U.S. EPA, Office of Cooperative Environmental Management (1601M), 1200 Pennsylvania Avenue, NW., Washington, DC 20460.
AGENCY: Food and Drug Administration, HHS.
SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by August 9, 2010.
ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285, or e-mailed to email@example.com. All comments should be identified with the OMB control number 0910-0543. Also include the FDA docket number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Elizabeth Berbakos, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-3792, Elizabeth.Berbakos@fda.hhs.gov.
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee:
Times and Dates:
8:30 a.m.-5 p.m., September 1, 2010.
8:30 a.m.-3 p.m., September 2, 2010.
Place: CDC, 1600 Clifton Road, NE., Tom Harkin Global Communications Center, Building 19, Room 232, Auditorium B, Atlanta, Georgia 30333.
Online Registration Required: In order to expedite the security clearance process at the CDC Roybal Campus located on Clifton Road, all CLIAC attendees are required to register for the meeting online at least 14 days in advance at http://wwwn.cdc.gov/cliac/default.aspx by clicking the "Register for a Meeting'' link and completing all forms according to the instructions given. Please complete all the required fields before submitting your registration and submit no later than August 17, 2010.
Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people.
Purpose: This Committee is charged with providing scientific and technical advice and guidance to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the need for, and the nature of, revisions to the standards under which clinical laboratories are regulated; the impact on medical and laboratory practice of proposed revisions to the standards; and the modification of the standards to accommodate technological advances.
Matters to be Discussed: The agenda will include agency updates from the CDC, the Centers for Medicare & Medicaid Services, and the Food and Drug Administration. Reports and Committee discussion will address issues pertaining to cytology testing and workload recording; the electronic exchange of laboratory information; and consideration of proposals from the CLIAC proficiency testing workgroup. Agenda items are subject to change as priorities dictate.
Providing Oral or Written Comments: It is the policy of CLIAC to accept written public comments and provide a brief period for oral public comments whenever possible.
Oral Comments: In general, each individual or group requesting to make an oral presentation will be limited to a total time of five minutes (unless otherwise indicated). Speakers must also submit their comments in writing for inclusion in the meeting's Summary Report. To assure adequate time is scheduled for public comments, individuals or groups planning to make an oral presentation should, when possible, notify the contact person below at least one week prior to the meeting date.
Written Comments: For individuals or groups unable to attend the meeting, CLIAC accepts written comments until the date of the meeting (unless otherwise stated). However, the comments should be received at least one week prior to the meeting date so that the comments may be made available to the Committee for their consideration and public distribution. Written comments, one hard copy with original signature, should be provided to the contact person below. Written comments will be included in the meeting's Summary Report.
Contact Person for Additional Information: Nancy Anderson, Chief, Laboratory Practice Standards Branch, Division of Laboratory Science and Standards (proposed), Laboratory Science, Policy and Practice Program Office (LSPPPO) (proposed), Office of Surveillance, Epidemiology and Laboratory Services (proposed), Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 30333; telephone (404) 498-2741; fax (404) 498- 2219; or via e-mail at Nancy.Anderson@cdc.hhs.gov.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for CDC and the Agency for Toxic Substances and Disease Registry.
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of request for nominations for public members.
SUMMARY: Section 921 (now Section 941 of the Public Health Service Act (PHS Act)), 42 U.S.C. 299c, established a National Advisory Council for Healthcare Research and Quality (the Council). The Council is to advise the Secretary of HHS (Secretary) and the Director of the Agency for Healthcare Research and Quality (AHRQ) on activities proposed or undertaken to carry out the agency mission including providing guidance on (A) Priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships.
Seven current members' terms will expire in November 2010. To fill these positions in accordance with the legislative mandate establishing the Council, we are seeking individuals who are distinguished: (1) In the conduct of research, demonstration projects, and evaluations with respect to health care; (2) in the fields of health care quality research or health care improvement; (3) in the practice of medicine; (4) in other health professions; (5) in the fields of health care economics, information systems, law, ethics, business, or public policy; and (6) individuals who could represent the interests of patients and consumers of health care; and (7) the private health care sector (including health plans, providers, and purchasers) possibly including distinguished administrators of health care delivery systems., Individuals are particularly sought with experience and success in activities specified in the summary above.
DATES: Nominations should be received on or before 60 days after date of publication.
ADDRESSES: Nominations should be sent to Ms. Karen Brooks, AHRQ, 540 Gaither Road, Room 3006, Rockville, Maryland 20850. Nominations may also be e-mailed to mailto: AHRQ National Advisory Council@AHRQ.hhs.gov or faxed to (301) 427-1201.
FOR FURTHER INFORMATION CONTACT: Ms. Karen Brooks, AHRQ, at (301) 427- 1801.
The NCEH/ATSDR is soliciting nominations for possible membership on the BSC. The BSC, NCEH/ATSDR provides advice and guidance to the Secretary, HHS; the Director, CDC and the Director, NCEH/ATSDR, regarding program goals, objectives, strategies, and priorities in fulfillment of the agencies' mission to protect and promote people's health. The Board provides advice and guidance to help NCEH/ATSDR work more efficiently and effectively with its various constituents and to fulfill its mission in protecting America's health.
Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the Board's objectives. Nominees will be selected from experts having experience in preventing human diseases and disabilities caused by environmental conditions. Experts in the disciplines of toxicology, epidemiology, environmental or occupational medicine, behavioral science, risk assessment, exposure assessment, and experts in public health and other related disciplines will be considered. Consideration is given to representation from diverse geographic areas, gender, ethnic and minority groups, and the disabled. Members may be invited to serve up to four-year terms. Nominees must be U.S. citizens.
The following information must be submitted for each candidate: Name, affiliation, address, telephone number, and current curriculum vitae. E-mail addresses are requested if available.
Nominations should be sent, in writing, and postmarked by November 30, 2010 to: Sandra Malcom, Committee Management Specialist, NCEH/ ATSDR, CDC, 4770 Buford Highway (MS-F61), Chamblee, Georgia 30341. (E- mail address: sym6@CDC.GOV). Telephone and facsimile submissions cannot be accepted.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the National Center for Environmental Health/Agency for Toxic Substances and Disease Registry.
SUMMARY: The purpose of this RFI is to enhance the value of the National Nanotechnology Initiative (NNI) by reaching out to the nanotechnology stakeholder community for specific input for the next NNI Strategic Plan to be published in December 2010. This RFI refers to the NNI Goals identified from the 2007 Strategic Plan (http://www.nano.gov/NNIStrategicPlan_2007.pdf) as a starting point for questions covering themes such as research priorities, investment, coordination, partnerships, evaluation, and policy.
RFI Response Instructions: The White House Office of Science and Technology Policy is interested in responses that address one or more of the following Questions below that are broadly categorized under Goals and Objectives; Research Priorities; Investment; Coordination and Partnerships; Evaluation; and Policy as related to the NNI. When submitting your response, please indicate: (1) The question(s) you are answering, and (2) which of the four NNI goals to which it applies. Please be specific and concise.
Responses to this RFI should be submitted by 11:59 p.m. Eastern Time on August 15, 2010. (Submissions prior to the July 13-14, 2010 "NNI Strategic Plan Stakeholder Workshop'' (http://www.nano.gov/html/meetings/NNISPWorkshop/index.html) may also inform dialogues at this event.) Responses to this RFI must be delivered electronically in the body of or as an attachment to an e-mail sent to NNIStrategy@ostp.gov. Additionally, OSTP intends to stage an online public comment event July 13-August 15, 2010 to solicit input on the NNI Strategic Plan. For details on this online event, see http://www.whitehouse.gov/ostp/NNIStrategy/.
Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract or issue a grant. Information obtained as a result of this RFI may be used by the government for program planning on a non-attribution basis. Do not include any information that might be considered proprietary or confidential.